| Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial EM Bulger, S May, KJ Brasel, M Schreiber, JD Kerby, SA Tisherman, ... Jama 304 (13), 1455-1464, 2010 | 356 | 2010 |
| Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial MS Sissoko, SA Healy, A Katile, F Omaswa, I Zaidi, EE Gabriel, B Kamate, ... The Lancet infectious diseases 17 (5), 498-509, 2017 | 328 | 2017 |
| Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve … KR Talaat, RD Ellis, J Hurd, A Hentrich, E Gabriel, NA Hynes, KM Rausch, ... PloS one 11 (10), e0163144, 2016 | 149 | 2016 |
| Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine … PB Gilbert, EE Gabriel, X Miao, X Li, SC Su, J Parrino, ISF Chan The Journal of infectious diseases 210 (10), 1573-1581, 2014 | 101 | 2014 |
| Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy H Babu, AT Ambikan, EE Gabriel, S Svensson Akusjärvi, AN Palaniappan, ... Frontiers in immunology 10, 1965, 2019 | 99 | 2019 |
| Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose … I Sagara, SA Healy, MH Assadou, EE Gabriel, M Kone, K Sissoko, ... The Lancet Infectious Diseases 18 (9), 969-982, 2018 | 99 | 2018 |
| Survival increases with CPR by emergency medical services before defibrillation of out-of-hospital ventricular fibrillation or ventricular tachycardia: observations from the … SM Bradley, EE Gabriel, TP Aufderheide, R Barnes, J Christenson, ... Resuscitation 81 (2), 155-162, 2010 | 84 | 2010 |
| Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design P Kunwar, N Hawkins, WL Dinges, Y Liu, EE Gabriel, DA Swan, ... PLoS One 8 (5), e64405, 2013 | 70 | 2013 |
| Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination DN Forthal, EE Gabriel, A Wang, G Landucci, TB Phan Blood, The Journal of the American Society of Hematology 120 (14), 2836-2842, 2012 | 61 | 2012 |
| Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people living with human immunodeficiency virus and … I Sereti, V Sheikh, D Shaffer, N Phanuphak, E Gabriel, J Wang, MC Nason, ... Clinical Infectious Diseases 71 (3), 652-660, 2020 | 60 | 2020 |
| Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice SA Healy, C Anderson, BJ Swihart, A Mwakingwe, EE Gabriel, ... The Journal of clinical investigation 131 (7), 2021 | 59 | 2021 |
| Pooled-peptide epitope mapping strategies are efficient and highly sensitive: an evaluation of methods for identifying human T cell epitope specificities in large-scale HIV … A Fiore-Gartland, BA Manso, DP Friedrich, EE Gabriel, G Finak, Z Moodie, ... PloS one 11 (2), e0147812, 2016 | 51 | 2016 |
| MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load H Janes, N Frahm, A DeCamp, M Rolland, E Gabriel, J Wolfson, T Hertz, ... Public Library of Science 7 (8), e43396, 2012 | 43 | 2012 |
| A sequential phase 2b trial design for evaluating vaccine efficacy and immune correlates for multiple HIV vaccine regimens PB Gilbert, D Grove, E Gabriel, Y Huang, G Gray, S Hammer | 43 | 2011 |
| Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells OD Defawe, Y Fong, E Vasilyeva, M Pickett, DK Carter, E Gabriel, ... Journal of immunological methods 382 (1-2), 117-128, 2012 | 41 | 2012 |
| Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy EE Gabriel, PB Gilbert Biostatistics 15 (2), 251-265, 2014 | 40 | 2014 |
| Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential BP Gonçalves, I Sagara, M Coulibaly, Y Wu, MH Assadou, A Guindo, ... Scientific reports 7 (1), 14267, 2017 | 38 | 2017 |
| Causal estimands and confidence intervals associated with Wilcoxon‐Mann‐Whitney tests in randomized experiments MP Fay, EH Brittain, JH Shih, DA Follmann, EE Gabriel Statistics in Medicine 37 (20), 2923-2937, 2018 | 29 | 2018 |
| The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer A Crippa, B De Laere, A Discacciati, B Larsson, JT Connor, EE Gabriel, ... Trials 21, 1-10, 2020 | 28 | 2020 |
| Comparing and combining biomarkers as principal surrogates for time‐to‐event clinical endpoints EE Gabriel, MC Sachs, PB Gilbert Statistics in medicine 34 (3), 381-395, 2015 | 26 | 2015 |
Michael C SachsUniversity of CopenhagenAdresse e-mail validée de sund.ku.dk
